No Data
China Galaxy Securities: Deepseek is sparking a trend in AI Medical, which is expected to continuously enhance the valuation of the Medical Sector.
Medical is one of the most important and promising scenarios for AI applications, primarily centered on the resonance between AI large model inference capabilities and Medical Big Data. Industry pharmaceutical companies are rapidly deploying localized applications of deepseek, significantly enhancing the performance of specialized large models.
Lepu Healthcare: 2024 Annual Results Forecast
Lepu Medical Technology (300003.SZ) plans to invest no more than 0.2 billion yuan to participate in the establishment of a healthcare industry merger and acquisition Fund in Suzhou.
Lepu Medical Technology (300003.SZ) announced that the company has cooperated with the professional investment institution Suzhou Lepu Suwing Consulting Partnership (has...
Shengnuo Biotechnology (688117.SH): Lepu Medical Technology has cumulatively reduced its shareholding by 0.7912%.
On December 26, Gelonghui reported that Shengnuo Biology (688117.SH) announced that the company recently received a notification letter from Lepu Medical Technology regarding the results of shareholding reduction. As of the date of this announcement, Lepu Medical Technology has cumulatively reduced its shareholding by 889,445 shares through centralized bidding, accounting for 0.7912% of the company's total share capital. After the reduction, Lepu Medical Technology holds 5,272,000 shares of the company, accounting for 4.6896% of the company's total share capital, and this shareholding reduction plan has reached its expiration.
Lepu Medical Technology (300003.SZ): The transcatheter implanted aortic valve system has received registration approval.
Lepu Medical Technology (300003.SZ) announced that its subsidiary Lepu Xintai's product ScienCro ...
Lepu Biopharma Renews Procurement Contract With Controlling Shareholder
